REGISTERED NUMBER: 13416130 (England and Wales)

Report of the Director and

Financial Statements for the Year Ended 31 May 2025

for

MARMADUKE MEDICAL LIMITED

Page

Company Information

1

Report of the Director

2

Income Statement

3

Balance Sheet

4

Notes to the Financial Statements

5

DIRECTOR:

DR S HASAN

SECRETARY:

REGISTERED OFFICE:

16 SPENCER WALK

LONDON

SW15 1PL

REGISTERED NUMBER:

13416130 (England and Wales)

ACCOUNTANTS:

B MEHTA & CO

102

STREATFIELD ROAD

HARROW

Middlesex

HA3 9BT

The director presents her report with the financial statements of the company for the year ended 31 May 2025.

PRINCIPAL ACTIVITY

The principal activity of the company in the year under review was that of Medical Consultancy Services

DIRECTOR

DR S HASAN held office during the whole of the period from 1 June 2024 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:

DR S HASAN - Director

25 September 2025

TURNOVER

243,709

328,539

Cost of sales

30,447

82,403

GROSS PROFIT

213,262

246,136

Distribution costs

30,900

40,600

Administrative expenses

156,200

174,588

187,100

215,188

OPERATING PROFIT and

PROFIT BEFORE TAXATION

26,162

30,948

Tax on profit

4,126

5,540

PROFIT FOR THE FINANCIAL YEAR

22,036

25,408

FIXED ASSETS

Tangible assets

5

44,147

53,397

CURRENT ASSETS

Cash at bank

165,769

163,523

CREDITORS

Amounts falling due within one year

6

90,975

112,853

NET CURRENT ASSETS

74,794

50,670

TOTAL ASSETS LESS CURRENT LIABILITIES

118,941

104,067

CREDITORS

Amounts falling due after more than one year

7

-

7,162

NET ASSETS

118,941

96,905

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

118,841

96,805

118,941

96,905

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 25 September 2025 and were signed by:

DR S HASAN - Director

1.	STATUTORY INFORMATION

MARMADUKE MEDICAL LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	OPERATING PROFIT

The operating profit is stated after charging:

31.5.25

31.5.24

£

£

Depreciation - owned assets

6,635

8,047

5.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

Computer

fittings

vehicles

equipment

Totals

£

£

£

£

COST

At 1 June 2024

35,282

35,500

3,560

74,342

Additions

-

25,028

-

25,028

Disposals

-

(35,500

)

-

(35,500

)

At 31 May 2025

35,282

25,028

3,560

63,870

DEPRECIATION

At 1 June 2024

11,491

7,857

1,597

20,945

Charge for year

4,280

2,002

353

6,635

Eliminated on disposal

-

(7,857

)

-

(7,857

)

At 31 May 2025

15,771

2,002

1,950

19,723

NET BOOK VALUE

At 31 May 2025

19,511

23,026

1,610

44,147

At 31 May 2024

23,791

27,643

1,963

53,397

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.5.25

31.5.24

£

£

Taxation and social security

5,174

23,762

Other creditors

85,801

89,091

90,975

112,853

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.5.25

31.5.24

£

£

Hire purchase contracts

-

7,162

Amounts falling due in more than five years:

Repayable by instalments

Hire purchase

7,162

7,162